The effect of Compassion Focused Therapy on psychological well­being in women with Lipoedema

Not Applicable

Completed

• Conditions: Lipoedema; Mental Health - Depression; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system; Depression

• Registration Number: ACTRN12622000283774
• Lead Sponsor: Central Queensland University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-02-15
• Study Completion: 2023-10-30
• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 94

Inclusion Criteria

An Australian resident
-Over 18 years-old
-Female (at birth)
-Diagnosed with lipoedema
-Able to gain access to zoom/telehealth technology in a private area (to keep confidentiality of other participants)

Exclusion Criteria

- currently undertaking another psychological intervention
- have, including a history of, conditions known to affect cognitive performance (such as traumatic brain injury, dementia, recent experience of seizures or neurological disruption)
- have changed medication related to your psychological health in the past month

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depression assessed using the Patient Health Questionnaire( PHQ-9)[ Baseline, post-intervention (10 weeks post-intervention commencement, primary endpoint), and follow-up (8 weeks post-intervention, and 24 weeks post-intervention completion)..];Compassion assessed using the Compassion Motivation and Action Scales (CMAS)[ Baseline, post-intervention (10 weeks post-intervention commencement, primary endpoint), and follow-up (8 weeks post-intervention, and 24 weeks post intervention completion).]

Secondary Outcome Measures

Name	Time	Method
Social context - self relating assessed with Fears of Compassion Scale (FCS)[ Baseline, post-intervention (10 weeks post-intervention commencement), and follow-up (8 weeks post-intervention, and 24 weeks post intervention completion).];A subset of participants, randomly selected from enrolled participants, microbiome composition. This will be collected via stool samples in an easy to use swab method and will be profiled with metagenomic sequencing. [ Baseline, post-intervention (10 weeks post-intervention commencement)];Well-being assessed with Mental Health Continuum-short Form ( MHC-SF)[ Baseline, post-intervention (10 weeks post-intervention commencement), and follow-up (8 weeks post-intervention, and 24 weeks post intervention completion).]